Cargando…
PD‐L1 expression in megakaryocytes and its clinicopathological features in primary myelofibrosis patients
Myeloproliferative neoplasms (MPNs) are characterized by upregulation of proinflammatory cytokines and immune dysregulation, which provide a reasonable basis for immunotherapy in patients. Megakaryocytes are crucial in the pathogenesis of primary myelofibrosis (PMF), the most clinically aggressive s...
Autores principales: | Lee, Sze‐Hwei, Lin, Chien‐Chin, Wei, Chao‐Hong, Chang, Ko‐Ping, Yuan, Chang‐Tsu, Tsai, Cheng‐Hong, Liu, Jia‐Hao, Hou, Hsin‐An, Tang, Jih‐Lu, Chou, Wen‐Chien, Tien, Hwei‐Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8682945/ https://www.ncbi.nlm.nih.gov/pubmed/34480529 http://dx.doi.org/10.1002/cjp2.240 |
Ejemplares similares
-
ASXL1 mutation confers poor prognosis in primary myelofibrosis patients with low JAK2V617F allele burden but not in those with high allele burden
por: Wang, Yu-Hung, et al.
Publicado: (2020) -
Clinicopathologic features and responses to radiotherapy of myeloid sarcoma
por: Chen, Wan-Yu, et al.
Publicado: (2013) -
High expression of dedicator of cytokinesis 1 (DOCK1) confers poor prognosis in acute myeloid leukemia
por: Lee, Sze-Hwei, et al.
Publicado: (2017) -
Distinct clinical and biological characteristics of acute myeloid leukemia with higher expression of long noncoding RNA KIAA0125
por: Wang, Yu-Hung, et al.
Publicado: (2020) -
Is it primary myelofibrosis or chronic megakaryocytic leukemia?
por: Lichtman, Marshall A.
Publicado: (2022)